0.85
+0(+0.00%)
Currency In USD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1012
First IPO Date
June 16, 2022
| Name | Title | Pay | Year Born |
| Vilhelm Robert Wessman | Chief Executive Officer, Founder & Executive Chairman | 2.32M | 1969 |
| Balaji Venkataramanan Prasad | Chief Strategy Officer | 0 | N/A |
| Kathryn Gunnarsson | SVP Global Talent & People Experience | 0 | N/A |
| Anthony Maffia | Chief Quality & Regulatory Officer | 0 | N/A |
| Benedikt Stefansson | Vice President of Investor Relations and Global Communications | 0 | N/A |
| Johann G Johannsson | Executive Vice President of Capital Markets and M&A | 0 | N/A |
| Joseph E. McClellan | Chief Operating Officer | 0 | 1974 |
| Uri Hillel | Chief Quality Officer | 0 | N/A |
| Agne Pasko | Vice President & Head of Business Development | 0 | N/A |
| Jenny Sif Steingrimsdottir | Vice President of People & Culture | 0 | N/A |
| Linda Jonsdottir | Chief Financial Officer | 0 | 1978 |
| Tanya Zharov | General Counsel | 0 | 1967 |
Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.